Pierre Fabre Laboratories y Vernalis anuncian una colaboración para el estudio y desarrollo de medicamentos oncológicos CASTRES, Francia y CAMBRIDGE, Reino Unido , 25 de septiembre de 2023 /PRNewswire/ — Pierre Fabre Laboratories y Vernalis (I+D) Ltd (“Vernalis”), filial de propiedad…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.